Skip to main content
Top
Published in: BMC Health Services Research 1/2017

Open Access 01-12-2017 | Research article

To what extent are psychiatrists aware of the comorbid somatic illnesses of their patients with serious mental illnesses? – a cross-sectional secondary data analysis

Authors: Christina Dornquast, Juliane Tomzik, Thomas Reinhold, Matthias Walle, Norbert Mönter, Anne Berghöfer

Published in: BMC Health Services Research | Issue 1/2017

Login to get access

Abstract

Background

Somatic comorbidities are a serious problem in patients with severe mental illnesses. These comorbidities often remain undiagnosed for a long time. In Germany, physicians are not allowed to access patients’ health insurance data and do not have routine access to documentation from other providers of health care. Against this background, the objective of this article was to investigate psychiatrists’ knowledge of relevant somatic comorbidities in their patients with severe mental illnesses.

Methods

Cross-sectional secondary data analysis was performed using primary data from a prospective study evaluating a model of integrated care of patients with serious mental illnesses. The primary data were linked with claims data from health insurers. Patients’ diagnoses were derived on the basis of the ICD-10 and the Anatomical Therapeutic Chemical (ATC) classification system. Diabetes, hypertension, coronary artery disease (CAD), hyperlipidaemia, glaucoma, osteoporosis, polyarthritis and chronic obstructive pulmonary disease (COPD) were selected for evaluation. We compared the number of diagnoses reported in the psychiatrists’ clinical report forms with those in the health insurance data.

Results

The study evaluated records from 1,195 patients with severe mental illnesses. The frequency of documentation of hypertension ranged from 21% in claims data to 4% in psychiatrists’ documentation, for COPD from 12 to 0%, respectively, and for diabetes from 7 to 2%, respectively. The percentage of diagnoses deduced from claims data but not documented by psychiatrists ranged from 68% for diabetes and 83% for hypertension, to 90% for CAD to 98% for COPD.

Conclusions

The majority of psychiatrists participating in the integrated care programme were insufficiently aware of the somatic comorbidities of their patients. We support allowing physicians to access patients’ entire medical records to increase their knowledge of patients’ medical histories and, consequently, to increase the safety and quality of care.
Literature
1.
go back to reference Baumeister H, Härter M. Körperliche Beschwerden bei Patienten mit psychischen Störungen. Z Psychiatr Psychol Psychother. 2007;55(1):9–19. Baumeister H, Härter M. Körperliche Beschwerden bei Patienten mit psychischen Störungen. Z Psychiatr Psychol Psychother. 2007;55(1):9–19.
2.
go back to reference Wells KB, Golding JM, Burnam MA. Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Gen Hosp Psychiatry. 1989;11(5):320–7.CrossRefPubMed Wells KB, Golding JM, Burnam MA. Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Gen Hosp Psychiatry. 1989;11(5):320–7.CrossRefPubMed
3.
go back to reference Wells KB, Golding JM, Burnam MA. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatr. 1989;146(11):1440–6.CrossRefPubMed Wells KB, Golding JM, Burnam MA. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatr. 1989;146(11):1440–6.CrossRefPubMed
4.
go back to reference Hewer W, Füeßl H. Körperliche Erkrankungen bei psychiatrischen Patienten–Teil I. Fortschritte der Neurologie·. Psychiatrie. 2009;77(12):720–37. Hewer W, Füeßl H. Körperliche Erkrankungen bei psychiatrischen Patienten–Teil I. Fortschritte der Neurologie·. Psychiatrie. 2009;77(12):720–37.
5.
go back to reference Horvitz-Lennon M, Kilbourne AM, Pincus HA. From silos to bridges: meeting the general health care needs of adults with severe mental illnesses. Health Aff. 2006;25(3):659–69.CrossRef Horvitz-Lennon M, Kilbourne AM, Pincus HA. From silos to bridges: meeting the general health care needs of adults with severe mental illnesses. Health Aff. 2006;25(3):659–69.CrossRef
6.
go back to reference Kilbourne AM, Morden NE, Austin K, Ilgen M, McCarthy JF, Dalack G, Blow FC. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen Hosp Psychiatry. 2009;31(6):555–63.CrossRefPubMedPubMedCentral Kilbourne AM, Morden NE, Austin K, Ilgen M, McCarthy JF, Dalack G, Blow FC. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen Hosp Psychiatry. 2009;31(6):555–63.CrossRefPubMedPubMedCentral
7.
go back to reference Osborn DP, Nazareth I, King MB. Risk for coronary heart disease in people with severe mental illness Cross-sectional comparative study in primary care. Br J Psychiatry. 2006;188(3):271–7.CrossRefPubMed Osborn DP, Nazareth I, King MB. Risk for coronary heart disease in people with severe mental illness Cross-sectional comparative study in primary care. Br J Psychiatry. 2006;188(3):271–7.CrossRefPubMed
8.
go back to reference Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom’s General Practice Research Database. Arch Gen Psychiatry. 2007;64(2):242–9.CrossRefPubMed Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom’s General Practice Research Database. Arch Gen Psychiatry. 2007;64(2):242–9.CrossRefPubMed
9.
go back to reference Koran LM, Sox H, Marton K, Moltzen S, Sox C, Kraemer H, Imai K, Kelsey T, Rose T, Levin L. Medical evaluation of psychiatric patients. Arch Gen Psychiatry. 1989;46(8):733–40.CrossRefPubMed Koran LM, Sox H, Marton K, Moltzen S, Sox C, Kraemer H, Imai K, Kelsey T, Rose T, Levin L. Medical evaluation of psychiatric patients. Arch Gen Psychiatry. 1989;46(8):733–40.CrossRefPubMed
10.
go back to reference van Hasselt FM, Schorr SG, Mookhoek EJ, Brouwers JR, Loonen AJ, Taxis K. Gaps in health care for the somatic health of outpatients with severe mental illness. Int J Ment Health Nurs. 2013;22(3):249–55.CrossRefPubMed van Hasselt FM, Schorr SG, Mookhoek EJ, Brouwers JR, Loonen AJ, Taxis K. Gaps in health care for the somatic health of outpatients with severe mental illness. Int J Ment Health Nurs. 2013;22(3):249–55.CrossRefPubMed
11.
go back to reference Druss BG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry. 2007;68 Suppl 4:40–4.PubMed Druss BG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry. 2007;68 Suppl 4:40–4.PubMed
12.
go back to reference Vreeland B. Bridging the gap between mental and physical health: A multidisciplinary approach. J Clin Psychiatry. 2007;68 Suppl 4:26–33.PubMed Vreeland B. Bridging the gap between mental and physical health: A multidisciplinary approach. J Clin Psychiatry. 2007;68 Suppl 4:26–33.PubMed
13.
go back to reference Sandson NB, Armstrong SC, Cozza KL. An overview of psychotropic drug-drug interactions. Psychosomatics. 2005;46(5):464–94.CrossRefPubMed Sandson NB, Armstrong SC, Cozza KL. An overview of psychotropic drug-drug interactions. Psychosomatics. 2005;46(5):464–94.CrossRefPubMed
14.
go back to reference Spina E, Santoro V, D’Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther. 2008;30(7):1206–27.CrossRefPubMed Spina E, Santoro V, D’Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther. 2008;30(7):1206–27.CrossRefPubMed
15.
go back to reference Guo JJ, Wu J, Kelton CM, Jing Y, Fan H, Keck PE, Patel NC. Exposure to potentially dangerous drug-drug interactions involving antipsychotics. Psychiatr Serv. 2012;63:1080–8.CrossRefPubMed Guo JJ, Wu J, Kelton CM, Jing Y, Fan H, Keck PE, Patel NC. Exposure to potentially dangerous drug-drug interactions involving antipsychotics. Psychiatr Serv. 2012;63:1080–8.CrossRefPubMed
16.
go back to reference Ostermann JK, Berghöfer A, Andersohn F, Fischer F. Frequency and clinical relevance of potential cytochrome P450 drug interactions in a psychiatric patient population. BMC Health Serv Res. 2016;16:482. Ostermann JK, Berghöfer A, Andersohn F, Fischer F. Frequency and clinical relevance of potential cytochrome P450 drug interactions in a psychiatric patient population. BMC Health Serv Res. 2016;16:482.
17.
go back to reference Fischer F, Hoffmann K, Mönter N, Walle M, Beneke R, Negenborn S, Weinmann S, Willich S, Berghöfer A. Kostenevaluation eines Modells der Integrierten Versorgung für schwer psychisch Kranke. Das Gesundheitswesen. 2014;76(02):86–95.PubMed Fischer F, Hoffmann K, Mönter N, Walle M, Beneke R, Negenborn S, Weinmann S, Willich S, Berghöfer A. Kostenevaluation eines Modells der Integrierten Versorgung für schwer psychisch Kranke. Das Gesundheitswesen. 2014;76(02):86–95.PubMed
18.
go back to reference Wittchen H, Saß H, Zaudig M, Koehler K. Diagnostische Kriterien und Differentialdiagnosen des diagnostischen und statistischen Manuals psychischer Störungen DSM III-R Basel. Weinheim: Beltz; 1989. Wittchen H, Saß H, Zaudig M, Koehler K. Diagnostische Kriterien und Differentialdiagnosen des diagnostischen und statistischen Manuals psychischer Störungen DSM III-R Basel. Weinheim: Beltz; 1989.
19.
go back to reference Weyer G. Internationale Skalen für Psychiatrie. Göttingen: Beltz Test; 2005. Weyer G. Internationale Skalen für Psychiatrie. Göttingen: Beltz Test; 2005.
20.
go back to reference Chini F, Pezzotti P, Orzella L, Borgia P, Guasticchi G. Can we use the pharmacy data to estimate the prevalence of chronic conditions? a comparison of multiple data sources. BMC Public Health. 2011;11(1):688.CrossRefPubMedPubMedCentral Chini F, Pezzotti P, Orzella L, Borgia P, Guasticchi G. Can we use the pharmacy data to estimate the prevalence of chronic conditions? a comparison of multiple data sources. BMC Public Health. 2011;11(1):688.CrossRefPubMedPubMedCentral
21.
go back to reference Halfon P, Eggli Y, Decollogny A, Seker E. Disease identification based on ambulatory drugs dispensation and in-hospital ICD-10 diagnoses: a comparison. BMC Health Serv Res. 2013;13(1):453.CrossRefPubMedPubMedCentral Halfon P, Eggli Y, Decollogny A, Seker E. Disease identification based on ambulatory drugs dispensation and in-hospital ICD-10 diagnoses: a comparison. BMC Health Serv Res. 2013;13(1):453.CrossRefPubMedPubMedCentral
22.
go back to reference Kuo RN, Dong Y-H, Liu J-P, Chang C-H, Shau W-Y, Lai M-S. Predicting healthcare utilization using a pharmacy-based metric with the WHO’s anatomic therapeutic chemical algorithm. Med Care. 2011;49(11):1031–9.CrossRefPubMed Kuo RN, Dong Y-H, Liu J-P, Chang C-H, Shau W-Y, Lai M-S. Predicting healthcare utilization using a pharmacy-based metric with the WHO’s anatomic therapeutic chemical algorithm. Med Care. 2011;49(11):1031–9.CrossRefPubMed
23.
go back to reference Lamers LM, van Vliet RC. The pharmacy-based cost group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy. 2004;68(1):113–21.CrossRefPubMed Lamers LM, van Vliet RC. The pharmacy-based cost group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy. 2004;68(1):113–21.CrossRefPubMed
24.
go back to reference Fransoo R, Martens P, The Need to Know Team, H P, C B, I K, A B, E A. The 2013 RHA Indicators Atlas. In: Winnipeg MV, editor. Manitoba Centre for Health Policy. 2013. Fransoo R, Martens P, The Need to Know Team, H P, C B, I K, A B, E A. The 2013 RHA Indicators Atlas. In: Winnipeg MV, editor. Manitoba Centre for Health Policy. 2013.
25.
go back to reference Hert M, Correll CU, Bobes J, Cetkovich‐Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Möller HJ, Ndetei DM. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77.CrossRef Hert M, Correll CU, Bobes J, Cetkovich‐Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Möller HJ, Ndetei DM. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77.CrossRef
26.
go back to reference Lederbogen F, Kopf D, Hewer W. Interdisziplinäre Station für psychisch Kranke mit erheblichen somatischen Komorbiditäten. Nervenarzt. 2008;79(9):1051–8. Lederbogen F, Kopf D, Hewer W. Interdisziplinäre Station für psychisch Kranke mit erheblichen somatischen Komorbiditäten. Nervenarzt. 2008;79(9):1051–8.
27.
go back to reference Lambert TJ, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med J Aust. 2003;178(9):S67.PubMed Lambert TJ, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med J Aust. 2003;178(9):S67.PubMed
28.
go back to reference R Core Team. R: A Language and Environment for Statistical Computing. 2013. R Core Team. R: A Language and Environment for Statistical Computing. 2013.
29.
go back to reference Kilbourne AM, McCarthy JF, Welsh D, Blow F. Recognition of co-occurring medical conditions among patients with serious mental illness. J Nerv Ment Dis. 2006;194(8):598–602.CrossRefPubMed Kilbourne AM, McCarthy JF, Welsh D, Blow F. Recognition of co-occurring medical conditions among patients with serious mental illness. J Nerv Ment Dis. 2006;194(8):598–602.CrossRefPubMed
30.
go back to reference Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, Lamberti S, D’Agostino RB, Stroup TS, Davis S. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80(1):45–53.CrossRefPubMed Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, Lamberti S, D’Agostino RB, Stroup TS, Davis S. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80(1):45–53.CrossRefPubMed
31.
go back to reference Parks J, Svendsen D, Singer P, Foti ME, Mauer B. Morbidity and mortality in people with serious mental illness. VA, USA: National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council Alexandria; 2006. Parks J, Svendsen D, Singer P, Foti ME, Mauer B. Morbidity and mortality in people with serious mental illness. VA, USA: National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council Alexandria; 2006.
32.
go back to reference Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatr. 2004;161(12):2317–9.CrossRefPubMed Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatr. 2004;161(12):2317–9.CrossRefPubMed
Metadata
Title
To what extent are psychiatrists aware of the comorbid somatic illnesses of their patients with serious mental illnesses? – a cross-sectional secondary data analysis
Authors
Christina Dornquast
Juliane Tomzik
Thomas Reinhold
Matthias Walle
Norbert Mönter
Anne Berghöfer
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2017
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-017-2106-6

Other articles of this Issue 1/2017

BMC Health Services Research 1/2017 Go to the issue